The BCCA promotes and provides certification in clinical anaplastology for the enhancement of patient care and professional practice.
Recommendations During COVID-19
BCCA Notification - Infection Control Recommendations for Clinical Anaplastologists Regarding COVID-19
BCCA update March 20, 2020
With recent global events with COVID-19, we realize it can be difficult to navigate this unprecedented and rapidly changing environment. Our profession covers diverse backgrounds and clinical settings with varying practices. The BCCA Board felt it prudent to communicate healthcare guidance for the profession of Anaplastology.
Following CDC guidance, the BCCA recommends suspending non-emergency care since infections may be transmitted within six feet of a patient.
See the BCCA guidance for working with emergent patients in the Steps You Can Take To Care For Emergency Cases. published on March 20, 2020 by the BCCA. This document should provide guidance, but it should not replace more stringent practice or institutional guidelines.
Additionally, we encourage Anaplastologists to refer to the CDC, WHO, and regional governments for guidance on safety of clinical practice. The BCCA Board is here to support you. We will continue to provide updates and recommendations in the coming weeks. If you have questions or concerns please contact Executive Director, Rachel Brooke at rachel@bcca-cca.com.
BCCA update March 27, 2020
The BCCA requests that you read the document Comply and Stay Up-to-Date with Government Regulations Regarding COVID-19 which outlines recommendations for pandemics. Please feel free to reach out with any questions or concerns you may have by contacting rachel@bcca-cca.com.